Anabolics help build new bone1

During the 5 to 6 years after menopause, there is an accelerated rate
of bone resorption that exceeds bone formation2

  • Average bone loss is 10%2
  • Some women may lose bone more rapidly, causing them to lose up to 20%2
    • In a study, each 15% decrease in BMD increased the relative risk of hip fracture by almost 2-fold3

Anabolics help1:

  • Increase osteoblast number and function4
  • Increase the formation of new bone1
  • Increase BMD5
  • Improve bone microarchitecture and strength5

Discover the mechanism of action of abaloparatide

Femur bone with no bone mass loss

Discover the mechanism of action
of abaloparatide

References: 1. Baron R, Hesse E. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab. 2012;97(2):311-325. 2. Ji M-X, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Diseases and Translational Medicine. 2015;1(1):9-13. 3. Schott AM, Cormier C, Hans D, et al, for the EPIDOS Group. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study. Osteoporos Int. 1998;8(3):246-254. 4. Khan AW, Khan A. Anabolic agents: a new chapter in the management of osteoporosis. J Obstet Gynaecol Can. 2006;28(2):136-141. 5. Girotra M, Rubin MR, Bilezikian JP. Anabolic agents for osteoporosis. What is their likely place in therapy? Treat Endocrinol. 2006;5(6):347-358.

This site is intended for HCPs in the United States.

All other trademarks are the property of their respective owners.

© 2017 Radius Health, Inc.   All rights reserved.    10/17.   TYM-US-00647

This site is intended for HCPs in the United States.
TYMLOS is a trademark of Radius Health, Inc.
All other trademarks are the property of their respective owners.

© 2017 Radius Health, Inc.
All rights reserved. 10/17.
TYM-US-00647